UT-15C Sustained-release
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UT-15C Sustained-release, covering 2021-05-10 to 2021-05-10. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension [Phase 3]